methylprednisolone has been researched along with Epilepsy Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayyappan, C; Jeyaraman, M; Karthik, SN; Meenakshi-Sundaram, S; Pandi, S; Sankaranarayanan, M | 1 |
| Cao, D; Chen, Y; Hu, Y; Li, L; Liao, J; Nariai, H; Wen, F; Zhai, Q; Zhao, X; Zhu, Y | 1 |
1 review(s) available for methylprednisolone and Epilepsy Syndromes
| Article | Year |
|---|---|
Super refractory status in a case of Febrile Infection-Related Epilepsy Syndrome due to hemophagocytic lymphocytic histiocytosis.
Topics: Adolescent; Anti-Inflammatory Agents; Anticonvulsants; Epileptic Syndromes; Fatal Outcome; Histiocytosis; Humans; Immune System Diseases; Lacosamide; Male; Methylprednisolone; Status Epilepticus | 2021 |
1 other study(ies) available for methylprednisolone and Epilepsy Syndromes
| Article | Year |
|---|---|
Scalp EEG high frequency oscillations as a biomarker of treatment response in epileptic encephalopathy with continuous spike-and-wave during sleep (CSWS).
Topics: Biomarkers; Brain Waves; Child; Epileptic Syndromes; Female; Glucocorticoids; Humans; Intelligence; Male; Methylprednisolone; Outcome Assessment, Health Care; Prospective Studies; Sleep; Status Epilepticus | 2019 |